Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07205341 · ClinicalTrials.gov registry record
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
A clinical trial of Aortic Valve Stenosis, sponsored by HemoCept.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07205341: Recruiting study of Aortic Valve Stenosis, sponsored by HemoCept.
NCT07205341 is a study of Aortic Valve Stenosis that is actively recruiting participants, run by HemoCept. The registered enrollment target is 20 participants, below the 1,043-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07205341, a study of Aortic Valve Stenosis, is actively recruiting participants, sponsored by HemoCept.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.
Primary Outcome
The primary endpoint is the ability of the HemoCept device to properly detect changes consistent with aortic valve pressure gradient values, measured by echocardiogram pre and post TAVR procedure.
Conditions Studied
Study Locations (1)
Colorado
- Boulder Heart - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-04-29 |
| Est. Completion | 2026-03 |
What NCT07205341 shows while recruiting
NCT07205341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,043-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 0 interventions.
NCT07205341 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07205341 about?
NCT07205341 is a clinical study titled "Detecting Changes in Arterial Blood Volume and Cardiac Efficiency". The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.
What is the current status of trial NCT07205341?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-04-29. Estimated completion is 2026-03.
What conditions does trial NCT07205341 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis.
Who is sponsoring clinical trial NCT07205341?
This trial is sponsored by HemoCept, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07205341 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07205341's enrollment target sits among peer trials
20 31st of 30 the lowest of 30 other Aortic Valve Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Valve Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
RECRUITING
-
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
RECRUITING
-
Platelet Adhesion in the Pathobiology of Aortic Stenosis
RECRUITING
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
MRI in Transcatheter Aortic Valve Replacement Patients
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI